Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. Senate passes anti-doping sports bill

Published 11/16/2020, 08:15 PM
Updated 11/16/2020, 08:20 PM
© Reuters. FILE PHOTO: USDA CEO Tygart attends an interview with Reuters during the WADA Symposium in Ecublens

(Reuters) - The United States Senate on Monday passed a bill that would allow U.S. justice officials to pursue criminal penalties against anyone involved in doping at an international events involving American athletes, sponsors or broadcasters.

The Rodchenkov Anti-Doping Act, which previously passed the House of Representatives unanimously, passed the Senate unopposed and needs to signature of the president to become law.

"The act will provide the tools needed to protect clean athletes and hold accountable international doping conspiracies that defraud sport, sponsors and that harm athletes," said Travis Tygart, the head of the United States Anti-Doping Agency (USADA).

"The act establishes criminal penalties for systems that carry out doping-fraud schemes that rob athletes, citizens and businesses," he said.

"It also protects whistleblowers from retaliation and provides restitution for athletes defrauded by conspiracies to dope.

"It is a monumental day in the fight for clean sport worldwide and we look forward to seeing the Act soon become law and help change the game for clean athletes for the good."

The bill has divided the anti-doping world.

The World Anti-Doping Agency (WADA) has expressed concern that the Rodchenkov Act, named after the whistleblower Grigory Rodchenkov who helped expose Russia's state-sponsored doping, could destabilize the global anti-doping effort while giving U.S. professional and college athletes a free pass.

There were also worries that the bill will impede the capacity to use whistleblowers by exposing them to multiple jurisdictions and preventing ‘substantial assistance’ deals.

"WADA, along with a number of governments and sports organizations, has legitimate concerns about the Rodchenkov Act," said WADA in an email to Reuters. "In particular, it may lead to overlapping laws in different jurisdictions that will compromise having a single set of rules for all athletes around the world.

"This harmonization of rules is at the very core of the global anti-doping program."

WADA has also questioned why the original draft of the bill included U.S. professional sport leagues and college athletes but were later removed.

© Reuters. FILE PHOTO: USDA CEO Tygart attends an interview with Reuters during the WADA Symposium in Ecublens

"WADA wishes also to understand why this legislation excludes vast areas of U.S. sport, in particular the professional leagues and all college sport," questioned WADA. "If it is not good enough for American sports, why is it fine for the rest of the world?"

Latest comments

Good to knowntheu are getting the important stuff done
WTH does this matter atm, really...lets get this virus under control woth a vaccine first.
This is why i dont support either party... their priorities are not in order. Smh
Who cares?
WADA does
this is what they're worried about in the Senate right now?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.